The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology

Cesare Gridelli, Benjamin Besse, Julie Renee Brahmer, Lucio Crinò, Enriqueta Felip, Filippo de Marinis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences